Litcius/Paper detail

Novel Peptide-Based Magnetic Nanoparticle for Mesenchymal Circulating Tumor Cells Detection

Fei Jia, Yuehua Wang, Zhiguo Fang, Jierong Dong, Fanghao Shi, Weikai Zhang, Zihua Wang, Zhiyuan Hu

2021Analytical Chemistry44 citationsDOI

Abstract

The monitoring of circulating tumor cells (CTCs) has recently served as a promising approach for assessing prognosis and evaluating cancer treatment. We have already developed a CTCs enrichment platform by EpCAM recognition peptide-functionalized magnetic nanoparticles (EP@MNPs). However, considering heterogeneous CTCs generated through epithelial-mesenchymal transition (EMT), mesenchymal CTCs would be missed with this method. Notably, N-cadherin, overexpressed on mesenchymal CTCs, can facilitate the migration of cancer cells. Hence, we screened a novel peptide targeting N-cadherin, NP, and developed a new CTCs isolation approach via NP@MNPs to complement EpCAM methods' deficiencies. NP@MNPs had a high capture efficiency (about 85%) of mesenchymal CTCs from spiked human blood. Subsequently, CTCs were captured and sequenced at the single-cell level via NP@MNPs and EP@MNPs, RNA profiles of which showed that epithelial and mesenchymal subgroups could be distinguished. Here, a novel CTCs isolation platform laid the foundation for mesenchymal CTCs isolation and subsequent molecular analysis.

Topics & Concepts

Circulating tumor cellMesenchymal stem cellChemistryLiquid biopsyEpithelial–mesenchymal transitionCancer researchMolecular biologyCancerMetastasisCell biologyBiologyBiochemistryGeneDownregulation and upregulationGeneticsCancer Cells and MetastasisCancer Genomics and DiagnosticsMetastasis and carcinoma case studies
Novel Peptide-Based Magnetic Nanoparticle for Mesenchymal Circulating Tumor Cells Detection | Litcius